Life Molecular Imaging Applauds the Publication of the IDEAS Study Aim I Results 8. April 20198. April 2019lifemolecular Read more: Publication of IDEAS study aim 1 results shows that Amyloid PET Imaging was associated with changes in clinical management for Medicare beneficiaries with MCI, dementia, cognitive impairment or Alzheimer’s Disease